Aktieanalys

Curasight: Brain cancer first indication for uTREAT - Redeye

{newsItem.title}

Redeye Publicerad: 12 Nov 09:02

Redeye gives a short comment on yesterday’s news that Curasight has announced brain cancer as the first indication for uTREAT.

Länk till analysen i sin helhet: https://www.redeye.se/research/1055559/curasight-brain-cancer-first-indication-for-utreat?utm_source=finwire&utm_medium=RSS

Nyheter om Curasight

Läses av andra just nu

Om aktien Curasight

Senaste nytt